Review



anti mouse cd3  (Bio X Cell)


Bioz Verified Symbol Bio X Cell is a verified supplier
Bioz Manufacturer Symbol Bio X Cell manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    Bio X Cell anti mouse cd3
    Anti Mouse Cd3, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 249 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/invivomab+anti+mouse+cd3%CE%B5/InVivoMAb+anti-mouse+CD3%CE%B5/us12594263-1012-12-14
    Average 97 stars, based on 249 article reviews
    anti mouse cd3 - by Bioz Stars, 2026-09
    97/100 stars

    Images

    Related Articles

    Sterility:

    Article Title: Enhancing anti-CD3 mAb-mediated diabetes remission in autoimmune diabetes through regulation of dynamin-related protein 1(Drp1)-mediated mitochondrial dynamics in exhausted CD8 + T-cell subpopulations
    Article Snippet: .. Then recipients randomly received either 10 μg of InVivoMAb anti-mouse CD3ε (Clone: 145-2C11, Bio X Cell) i.v. per day for 5 days [ ], or were administered 40 μg of IGRP 206–214 peptide in 20 μl sterile PBS (20 μg in 10 μl per nostril) intranasally per day for 3 days [ ]. ..

    Article Title: Enhancing anti-CD3 mAb-mediated diabetes remission in autoimmune diabetes through regulation of dynamin-related protein 1(Drp1)-mediated mitochondrial dynamics in exhausted CD8 + T-cell subpopulations.
    Article Snippet: .. Then recipients randomly received either 10 μg of InVivoMAb anti-mouse CD3ε (Clone: 145-2C11, Bio X Cell) i.v. per day for 5 days [49], or were administered 40 μg of IGRP206–214 peptide in 20 μl sterile PBS (20 μg in 10 μl per nostril) intranasally per day for 3 days [50]. ..

    Injection:

    Article Title: Escherichia coli promotes colorectal cancer metastasis by maintaining enhancer-promoter loops through releasing neutrophil extracellular traps
    Article Snippet: .. 3 d after the injection of MC38 cells or patient organoids, Anti-CD3 Antibody (OKT-3) (3 mg/kg, HY-P990864, MedChemExpress, NJ, USA), Anumigilimab (2 mg/kg, HY-P99440, MedChemExpress), Ca 2+ channel agonist 1 (4 mg/kg, HY-41076, MedChemExpress), Clodronate Liposomes (40337ES08, Yeasen, China), DMSO (HY-Y0320C, MedChemExpress), DNase I (10 mg/kg, 10104159001, Merck), GSK484 hydrochloride (4 mg/kg, HY-100514, MedChemExpress), GSK583 (4 mg/kg, HY-100339, MedChemExpress), InVivoMAb anti-mouse CD3ε (5 mg/kg, catalog number: BE0001-1, clone name: 145-2C11, Bio X Cell, PA, USA), InVivoMAb anti-mouse Ly6G (5 mg/kg, catalog number: BE0075, clone name: RB6-8C5, Bio X Cell), InVivoMAb rat IgG2a isotype control (5 mg/kg, catalog number: BE0251, clone name: RG7/1.30, Bio X Cell), JNK-IN-8 (3 mg/kg, HY-13319, MedChemExpress), JSH-23 (5 mg/kg, HY-13982, MedChemExpress), MLKL-IN-1 (5 mg/kg, HY-139878, MedChemExpress), NOD1/2 antagonist-1 (5 mg/kg, HY-146034, MedChemExpress), Paquinimod (5 mg/kg, HY-100442, MedChemExpress), PMA (5 mg/kg, P8139, Merck), p38 MAPK-IN-1 (5 mg/kg, HY-12839, MedChemExpress), SCH772984 (3 mg/kg, HY-50846, MedChemExpress), Sparstolonin B (5 mg/kg, HY-116213, MedChemExpress), or Stattic (5 mg/kg, HY-13818, MedChemExpress) were injected into the tail vein of mice once every three days for a total of five times. .. Chemical induction of CRC model: Mice received an intraperitoneal injection of AOM (10 mg/kg, HY-111375, MedChemExpress) and were given regular water for 14 d, followed by 7 d of 2.5% DSS (HY-116282C, MedChemExpress) in place of regular water, then regular water again for 14 d, alternating between DSS and regular water.

    Article Title: Escherichia coli promotes colorectal cancer metastasis by maintaining enhancer-promoter loops through releasing neutrophil extracellular traps.
    Article Snippet: .. 3 d after the injection of MC38 cells or patient organoids, Anti-CD3 Antibody (OKT-3) (3 mg/kg, HY-P990864, MedChemExpress, NJ, USA), Anumigilimab (2 mg/kg, HY-P99440, MedChemExpress), Ca2+ channel agonist 1 (4 mg/kg, HY-41076, MedChemExpress), Clodronate Liposomes (40337ES08, Yeasen, China), DMSO (HY-Y0320C, MedChemExpress), DNase I (10 mg/kg, 10104159001, Merck), GSK484 hydrochloride (4 mg/kg, HY-100514, MedChemExpress), GSK583 (4 mg/kg, HY-100339, MedChemExpress), InVivoMAb anti-mouse CD3ε (5 mg/kg, catalog number: BE0001-1, clone name: 145-2C11, Bio X Cell, PA, USA), InVivoMAb anti-mouse Ly6G (5 mg/kg, catalog number: BE0075, clone name: RB6-8C5, Bio X Cell), InVivoMAb rat IgG2a isotype control (5 mg/kg, catalog number: BE0251, clone name: RG7/1.30, Bio X Cell), JNK-IN-8 (3 mg/kg, HY-13319, MedChemExpress), JSH23 (5 mg/kg, HY-13982, MedChemExpress), MLKL-IN-1 (5 mg/kg, HY-139878, MedChemExpress), NOD1/2 antagonist-1 (5 mg/kg, HY-146034, MedChemExpress), Paquinimod (5 mg/kg, HY-100442, MedChemExpress), PMA (5 mg/kg, P8139, Merck), p38 MAPK-IN-1 (5 mg/kg, HY-12839, MedChemExpress), SCH772984 (3 mg/kg, HY-50846, MedChemExpress), Sparstolonin B (5 mg/kg, HY-116213, MedChemExpress), or Stattic (5 mg/kg, HY-13818, MedChemExpress) were injected into the tail vein of mice once every three days for a total of five times. (7) Chemical induction of CRC model: Mice received an intraperitoneal injection of AOM (10 mg/kg, HY-111375, MedChemExpress) and were given regular water for 14 d, followed by 7 d of 2.5% DSS (HY-116282C, MedChemExpress) in place of regular water, then regular water again for 14 d, alternating between DSS and regular water. (8) Strategy for constructing Atf3, Hnrnpk, Ncf4, Relb, or Ripk2-cKO mouse model: We selected Exon2-Exon3 of Atf3 transcript-201 and Exon5-Exon8 of Hnrnpk-202 as the flox region, respectively. ..

    Liposomes:

    Article Title: Escherichia coli promotes colorectal cancer metastasis by maintaining enhancer-promoter loops through releasing neutrophil extracellular traps
    Article Snippet: .. 3 d after the injection of MC38 cells or patient organoids, Anti-CD3 Antibody (OKT-3) (3 mg/kg, HY-P990864, MedChemExpress, NJ, USA), Anumigilimab (2 mg/kg, HY-P99440, MedChemExpress), Ca 2+ channel agonist 1 (4 mg/kg, HY-41076, MedChemExpress), Clodronate Liposomes (40337ES08, Yeasen, China), DMSO (HY-Y0320C, MedChemExpress), DNase I (10 mg/kg, 10104159001, Merck), GSK484 hydrochloride (4 mg/kg, HY-100514, MedChemExpress), GSK583 (4 mg/kg, HY-100339, MedChemExpress), InVivoMAb anti-mouse CD3ε (5 mg/kg, catalog number: BE0001-1, clone name: 145-2C11, Bio X Cell, PA, USA), InVivoMAb anti-mouse Ly6G (5 mg/kg, catalog number: BE0075, clone name: RB6-8C5, Bio X Cell), InVivoMAb rat IgG2a isotype control (5 mg/kg, catalog number: BE0251, clone name: RG7/1.30, Bio X Cell), JNK-IN-8 (3 mg/kg, HY-13319, MedChemExpress), JSH-23 (5 mg/kg, HY-13982, MedChemExpress), MLKL-IN-1 (5 mg/kg, HY-139878, MedChemExpress), NOD1/2 antagonist-1 (5 mg/kg, HY-146034, MedChemExpress), Paquinimod (5 mg/kg, HY-100442, MedChemExpress), PMA (5 mg/kg, P8139, Merck), p38 MAPK-IN-1 (5 mg/kg, HY-12839, MedChemExpress), SCH772984 (3 mg/kg, HY-50846, MedChemExpress), Sparstolonin B (5 mg/kg, HY-116213, MedChemExpress), or Stattic (5 mg/kg, HY-13818, MedChemExpress) were injected into the tail vein of mice once every three days for a total of five times. .. Chemical induction of CRC model: Mice received an intraperitoneal injection of AOM (10 mg/kg, HY-111375, MedChemExpress) and were given regular water for 14 d, followed by 7 d of 2.5% DSS (HY-116282C, MedChemExpress) in place of regular water, then regular water again for 14 d, alternating between DSS and regular water.

    Article Title: Escherichia coli promotes colorectal cancer metastasis by maintaining enhancer-promoter loops through releasing neutrophil extracellular traps.
    Article Snippet: .. 3 d after the injection of MC38 cells or patient organoids, Anti-CD3 Antibody (OKT-3) (3 mg/kg, HY-P990864, MedChemExpress, NJ, USA), Anumigilimab (2 mg/kg, HY-P99440, MedChemExpress), Ca2+ channel agonist 1 (4 mg/kg, HY-41076, MedChemExpress), Clodronate Liposomes (40337ES08, Yeasen, China), DMSO (HY-Y0320C, MedChemExpress), DNase I (10 mg/kg, 10104159001, Merck), GSK484 hydrochloride (4 mg/kg, HY-100514, MedChemExpress), GSK583 (4 mg/kg, HY-100339, MedChemExpress), InVivoMAb anti-mouse CD3ε (5 mg/kg, catalog number: BE0001-1, clone name: 145-2C11, Bio X Cell, PA, USA), InVivoMAb anti-mouse Ly6G (5 mg/kg, catalog number: BE0075, clone name: RB6-8C5, Bio X Cell), InVivoMAb rat IgG2a isotype control (5 mg/kg, catalog number: BE0251, clone name: RG7/1.30, Bio X Cell), JNK-IN-8 (3 mg/kg, HY-13319, MedChemExpress), JSH23 (5 mg/kg, HY-13982, MedChemExpress), MLKL-IN-1 (5 mg/kg, HY-139878, MedChemExpress), NOD1/2 antagonist-1 (5 mg/kg, HY-146034, MedChemExpress), Paquinimod (5 mg/kg, HY-100442, MedChemExpress), PMA (5 mg/kg, P8139, Merck), p38 MAPK-IN-1 (5 mg/kg, HY-12839, MedChemExpress), SCH772984 (3 mg/kg, HY-50846, MedChemExpress), Sparstolonin B (5 mg/kg, HY-116213, MedChemExpress), or Stattic (5 mg/kg, HY-13818, MedChemExpress) were injected into the tail vein of mice once every three days for a total of five times. (7) Chemical induction of CRC model: Mice received an intraperitoneal injection of AOM (10 mg/kg, HY-111375, MedChemExpress) and were given regular water for 14 d, followed by 7 d of 2.5% DSS (HY-116282C, MedChemExpress) in place of regular water, then regular water again for 14 d, alternating between DSS and regular water. (8) Strategy for constructing Atf3, Hnrnpk, Ncf4, Relb, or Ripk2-cKO mouse model: We selected Exon2-Exon3 of Atf3 transcript-201 and Exon5-Exon8 of Hnrnpk-202 as the flox region, respectively. ..

    Control:

    Article Title: Escherichia coli promotes colorectal cancer metastasis by maintaining enhancer-promoter loops through releasing neutrophil extracellular traps
    Article Snippet: .. 3 d after the injection of MC38 cells or patient organoids, Anti-CD3 Antibody (OKT-3) (3 mg/kg, HY-P990864, MedChemExpress, NJ, USA), Anumigilimab (2 mg/kg, HY-P99440, MedChemExpress), Ca 2+ channel agonist 1 (4 mg/kg, HY-41076, MedChemExpress), Clodronate Liposomes (40337ES08, Yeasen, China), DMSO (HY-Y0320C, MedChemExpress), DNase I (10 mg/kg, 10104159001, Merck), GSK484 hydrochloride (4 mg/kg, HY-100514, MedChemExpress), GSK583 (4 mg/kg, HY-100339, MedChemExpress), InVivoMAb anti-mouse CD3ε (5 mg/kg, catalog number: BE0001-1, clone name: 145-2C11, Bio X Cell, PA, USA), InVivoMAb anti-mouse Ly6G (5 mg/kg, catalog number: BE0075, clone name: RB6-8C5, Bio X Cell), InVivoMAb rat IgG2a isotype control (5 mg/kg, catalog number: BE0251, clone name: RG7/1.30, Bio X Cell), JNK-IN-8 (3 mg/kg, HY-13319, MedChemExpress), JSH-23 (5 mg/kg, HY-13982, MedChemExpress), MLKL-IN-1 (5 mg/kg, HY-139878, MedChemExpress), NOD1/2 antagonist-1 (5 mg/kg, HY-146034, MedChemExpress), Paquinimod (5 mg/kg, HY-100442, MedChemExpress), PMA (5 mg/kg, P8139, Merck), p38 MAPK-IN-1 (5 mg/kg, HY-12839, MedChemExpress), SCH772984 (3 mg/kg, HY-50846, MedChemExpress), Sparstolonin B (5 mg/kg, HY-116213, MedChemExpress), or Stattic (5 mg/kg, HY-13818, MedChemExpress) were injected into the tail vein of mice once every three days for a total of five times. .. Chemical induction of CRC model: Mice received an intraperitoneal injection of AOM (10 mg/kg, HY-111375, MedChemExpress) and were given regular water for 14 d, followed by 7 d of 2.5% DSS (HY-116282C, MedChemExpress) in place of regular water, then regular water again for 14 d, alternating between DSS and regular water.

    Article Title: Escherichia coli promotes colorectal cancer metastasis by maintaining enhancer-promoter loops through releasing neutrophil extracellular traps.
    Article Snippet: .. 3 d after the injection of MC38 cells or patient organoids, Anti-CD3 Antibody (OKT-3) (3 mg/kg, HY-P990864, MedChemExpress, NJ, USA), Anumigilimab (2 mg/kg, HY-P99440, MedChemExpress), Ca2+ channel agonist 1 (4 mg/kg, HY-41076, MedChemExpress), Clodronate Liposomes (40337ES08, Yeasen, China), DMSO (HY-Y0320C, MedChemExpress), DNase I (10 mg/kg, 10104159001, Merck), GSK484 hydrochloride (4 mg/kg, HY-100514, MedChemExpress), GSK583 (4 mg/kg, HY-100339, MedChemExpress), InVivoMAb anti-mouse CD3ε (5 mg/kg, catalog number: BE0001-1, clone name: 145-2C11, Bio X Cell, PA, USA), InVivoMAb anti-mouse Ly6G (5 mg/kg, catalog number: BE0075, clone name: RB6-8C5, Bio X Cell), InVivoMAb rat IgG2a isotype control (5 mg/kg, catalog number: BE0251, clone name: RG7/1.30, Bio X Cell), JNK-IN-8 (3 mg/kg, HY-13319, MedChemExpress), JSH23 (5 mg/kg, HY-13982, MedChemExpress), MLKL-IN-1 (5 mg/kg, HY-139878, MedChemExpress), NOD1/2 antagonist-1 (5 mg/kg, HY-146034, MedChemExpress), Paquinimod (5 mg/kg, HY-100442, MedChemExpress), PMA (5 mg/kg, P8139, Merck), p38 MAPK-IN-1 (5 mg/kg, HY-12839, MedChemExpress), SCH772984 (3 mg/kg, HY-50846, MedChemExpress), Sparstolonin B (5 mg/kg, HY-116213, MedChemExpress), or Stattic (5 mg/kg, HY-13818, MedChemExpress) were injected into the tail vein of mice once every three days for a total of five times. (7) Chemical induction of CRC model: Mice received an intraperitoneal injection of AOM (10 mg/kg, HY-111375, MedChemExpress) and were given regular water for 14 d, followed by 7 d of 2.5% DSS (HY-116282C, MedChemExpress) in place of regular water, then regular water again for 14 d, alternating between DSS and regular water. (8) Strategy for constructing Atf3, Hnrnpk, Ncf4, Relb, or Ripk2-cKO mouse model: We selected Exon2-Exon3 of Atf3 transcript-201 and Exon5-Exon8 of Hnrnpk-202 as the flox region, respectively. ..

    Mouse Assay:

    Article Title: Escherichia coli promotes colorectal cancer metastasis by maintaining enhancer-promoter loops through releasing neutrophil extracellular traps.
    Article Snippet: .. 3 d after the injection of MC38 cells or patient organoids, Anti-CD3 Antibody (OKT-3) (3 mg/kg, HY-P990864, MedChemExpress, NJ, USA), Anumigilimab (2 mg/kg, HY-P99440, MedChemExpress), Ca2+ channel agonist 1 (4 mg/kg, HY-41076, MedChemExpress), Clodronate Liposomes (40337ES08, Yeasen, China), DMSO (HY-Y0320C, MedChemExpress), DNase I (10 mg/kg, 10104159001, Merck), GSK484 hydrochloride (4 mg/kg, HY-100514, MedChemExpress), GSK583 (4 mg/kg, HY-100339, MedChemExpress), InVivoMAb anti-mouse CD3ε (5 mg/kg, catalog number: BE0001-1, clone name: 145-2C11, Bio X Cell, PA, USA), InVivoMAb anti-mouse Ly6G (5 mg/kg, catalog number: BE0075, clone name: RB6-8C5, Bio X Cell), InVivoMAb rat IgG2a isotype control (5 mg/kg, catalog number: BE0251, clone name: RG7/1.30, Bio X Cell), JNK-IN-8 (3 mg/kg, HY-13319, MedChemExpress), JSH23 (5 mg/kg, HY-13982, MedChemExpress), MLKL-IN-1 (5 mg/kg, HY-139878, MedChemExpress), NOD1/2 antagonist-1 (5 mg/kg, HY-146034, MedChemExpress), Paquinimod (5 mg/kg, HY-100442, MedChemExpress), PMA (5 mg/kg, P8139, Merck), p38 MAPK-IN-1 (5 mg/kg, HY-12839, MedChemExpress), SCH772984 (3 mg/kg, HY-50846, MedChemExpress), Sparstolonin B (5 mg/kg, HY-116213, MedChemExpress), or Stattic (5 mg/kg, HY-13818, MedChemExpress) were injected into the tail vein of mice once every three days for a total of five times. (7) Chemical induction of CRC model: Mice received an intraperitoneal injection of AOM (10 mg/kg, HY-111375, MedChemExpress) and were given regular water for 14 d, followed by 7 d of 2.5% DSS (HY-116282C, MedChemExpress) in place of regular water, then regular water again for 14 d, alternating between DSS and regular water. (8) Strategy for constructing Atf3, Hnrnpk, Ncf4, Relb, or Ripk2-cKO mouse model: We selected Exon2-Exon3 of Atf3 transcript-201 and Exon5-Exon8 of Hnrnpk-202 as the flox region, respectively. ..

    other:

    Article Title: Chemoradiotherapy-induced ACKR2 + tumor cells drive CD8 + T cell senescence and cervical cancer recurrence
    Article Snippet: InVivoMab anti-mouse CD3ε , BioXcell , Cat# BE0001-1; RRID: AB_1107634.



    Similar Products

    97
    Bio X Cell anti mouse cd3
    Anti Mouse Cd3, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/invivomab+anti+mouse+cd3%CE%B5/InVivoMAb+anti-mouse+CD3%CE%B5/us12594263-1012-12-14
    Average 97 stars, based on 1 article reviews
    anti mouse cd3 - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    97
    Bio X Cell plate coated anti cd3
    ( A ) Circos plots showing the percentage of cells from HC (Healthy control, n = 6), ICI ( n = 2), RAC (RA control, n = 5), or irAE ( n = 5). ( B ) Expression of CD45RA and CCR7 on CD8 + T cells. Right: Summaries of the percentage of cells from HC ( n = 53), irAE ( n = 29), RAC ( n = 41), and ICI ( n = 26). ( C ) Expression of CXCR3 and CCR6 on CD8 + T cells. Right: Summaries of T cell subsets. HC ( n = 45), irAE ( n = 27), RAC ( n = 31), and ICI ( n = 26). ( D ) The cytotoxic score was evaluated using the gene list identified previously . ( E ) Specific genes were evaluated on CD8 + T cells. ( F ) Pathways that were significantly enriched in the CD8 + T cells between irAE and ICI. NF-κB, nuclear factor κB; STAT5, signal transducer and activator of transcription 5; DN, down. Gene set enrichment analysis (GSEA) plots of the allograft rejection ( G ), oxidative phosphorylation ( H ), IFN-α response ( I ), and IFN-γ response ( J ) between irAE and ICI. NES, normalized enrichment score ( K to M ) PBMCs were stimulated with <t>plate-coated</t> <t>anti-CD3</t> and anti-CD28 (10 μg/ml) for 5 days. Mean fluorescence intensities (MFIs) of MitoTracker Green (MTG) (K), MitoTracker deep red (MTDR) (L) [HC ( n = 31), irAE ( n = 18), RAC ( n = 32), and ICI ( n = 16)] or Cy5-linked-1-amino-glucose (GluCy5) (M) [HC ( n = 35), irAE ( n = 20), RAC ( n = 36), and ICI ( n = 18)] in CD8 + T cells were presented. Expression was normalized to the HC in each experiment. ( N ) UMAP shows the presence or absence of T cell receptor (TCR) in the major immune cells across all the samples. ( O ) Pie charts showing the distribution of the top 100 TCR clones across different T cell subsets. Data in graphs represent mean ± SEM. Significance was tested by one-way analysis of variance (ANOVA). [(A) to (E) and (G) to (O)] ICI, ICI control.
    Plate Coated Anti Cd3, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/invivomab+anti+mouse+cd3%CE%B5/InVivoMAb+anti-mouse+CD3%CE%B5/pmc13041753-252-18-22
    Average 97 stars, based on 1 article reviews
    plate coated anti cd3 - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    97
    Bio X Cell anti cd3
    ( A ) Circos plots showing the percentage of cells from HC (Healthy control, n = 6), ICI ( n = 2), RAC (RA control, n = 5), or irAE ( n = 5). ( B ) Expression of CD45RA and CCR7 on CD8 + T cells. Right: Summaries of the percentage of cells from HC ( n = 53), irAE ( n = 29), RAC ( n = 41), and ICI ( n = 26). ( C ) Expression of CXCR3 and CCR6 on CD8 + T cells. Right: Summaries of T cell subsets. HC ( n = 45), irAE ( n = 27), RAC ( n = 31), and ICI ( n = 26). ( D ) The cytotoxic score was evaluated using the gene list identified previously . ( E ) Specific genes were evaluated on CD8 + T cells. ( F ) Pathways that were significantly enriched in the CD8 + T cells between irAE and ICI. NF-κB, nuclear factor κB; STAT5, signal transducer and activator of transcription 5; DN, down. Gene set enrichment analysis (GSEA) plots of the allograft rejection ( G ), oxidative phosphorylation ( H ), IFN-α response ( I ), and IFN-γ response ( J ) between irAE and ICI. NES, normalized enrichment score ( K to M ) PBMCs were stimulated with <t>plate-coated</t> <t>anti-CD3</t> and anti-CD28 (10 μg/ml) for 5 days. Mean fluorescence intensities (MFIs) of MitoTracker Green (MTG) (K), MitoTracker deep red (MTDR) (L) [HC ( n = 31), irAE ( n = 18), RAC ( n = 32), and ICI ( n = 16)] or Cy5-linked-1-amino-glucose (GluCy5) (M) [HC ( n = 35), irAE ( n = 20), RAC ( n = 36), and ICI ( n = 18)] in CD8 + T cells were presented. Expression was normalized to the HC in each experiment. ( N ) UMAP shows the presence or absence of T cell receptor (TCR) in the major immune cells across all the samples. ( O ) Pie charts showing the distribution of the top 100 TCR clones across different T cell subsets. Data in graphs represent mean ± SEM. Significance was tested by one-way analysis of variance (ANOVA). [(A) to (E) and (G) to (O)] ICI, ICI control.
    Anti Cd3, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/invivomab+anti+mouse+cd3%CE%B5/InVivoMAb+anti-mouse+CD3%CE%B5/pm41920990-307-18-22
    Average 97 stars, based on 1 article reviews
    anti cd3 - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    97
    Bio X Cell be0001
    ( A ) Circos plots showing the percentage of cells from HC (Healthy control, n = 6), ICI ( n = 2), RAC (RA control, n = 5), or irAE ( n = 5). ( B ) Expression of CD45RA and CCR7 on CD8 + T cells. Right: Summaries of the percentage of cells from HC ( n = 53), irAE ( n = 29), RAC ( n = 41), and ICI ( n = 26). ( C ) Expression of CXCR3 and CCR6 on CD8 + T cells. Right: Summaries of T cell subsets. HC ( n = 45), irAE ( n = 27), RAC ( n = 31), and ICI ( n = 26). ( D ) The cytotoxic score was evaluated using the gene list identified previously . ( E ) Specific genes were evaluated on CD8 + T cells. ( F ) Pathways that were significantly enriched in the CD8 + T cells between irAE and ICI. NF-κB, nuclear factor κB; STAT5, signal transducer and activator of transcription 5; DN, down. Gene set enrichment analysis (GSEA) plots of the allograft rejection ( G ), oxidative phosphorylation ( H ), IFN-α response ( I ), and IFN-γ response ( J ) between irAE and ICI. NES, normalized enrichment score ( K to M ) PBMCs were stimulated with <t>plate-coated</t> <t>anti-CD3</t> and anti-CD28 (10 μg/ml) for 5 days. Mean fluorescence intensities (MFIs) of MitoTracker Green (MTG) (K), MitoTracker deep red (MTDR) (L) [HC ( n = 31), irAE ( n = 18), RAC ( n = 32), and ICI ( n = 16)] or Cy5-linked-1-amino-glucose (GluCy5) (M) [HC ( n = 35), irAE ( n = 20), RAC ( n = 36), and ICI ( n = 18)] in CD8 + T cells were presented. Expression was normalized to the HC in each experiment. ( N ) UMAP shows the presence or absence of T cell receptor (TCR) in the major immune cells across all the samples. ( O ) Pie charts showing the distribution of the top 100 TCR clones across different T cell subsets. Data in graphs represent mean ± SEM. Significance was tested by one-way analysis of variance (ANOVA). [(A) to (E) and (G) to (O)] ICI, ICI control.
    Be0001, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/invivomab+anti+mouse+cd3%CE%B5/InVivoMAb+anti-mouse+CD3%CE%B5/pm41865369-322-49-45
    Average 97 stars, based on 1 article reviews
    be0001 - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    97
    Bio X Cell plate bound anti cd3
    ( A ) Circos plots showing the percentage of cells from HC (Healthy control, n = 6), ICI ( n = 2), RAC (RA control, n = 5), or irAE ( n = 5). ( B ) Expression of CD45RA and CCR7 on CD8 + T cells. Right: Summaries of the percentage of cells from HC ( n = 53), irAE ( n = 29), RAC ( n = 41), and ICI ( n = 26). ( C ) Expression of CXCR3 and CCR6 on CD8 + T cells. Right: Summaries of T cell subsets. HC ( n = 45), irAE ( n = 27), RAC ( n = 31), and ICI ( n = 26). ( D ) The cytotoxic score was evaluated using the gene list identified previously . ( E ) Specific genes were evaluated on CD8 + T cells. ( F ) Pathways that were significantly enriched in the CD8 + T cells between irAE and ICI. NF-κB, nuclear factor κB; STAT5, signal transducer and activator of transcription 5; DN, down. Gene set enrichment analysis (GSEA) plots of the allograft rejection ( G ), oxidative phosphorylation ( H ), IFN-α response ( I ), and IFN-γ response ( J ) between irAE and ICI. NES, normalized enrichment score ( K to M ) PBMCs were stimulated with <t>plate-coated</t> <t>anti-CD3</t> and anti-CD28 (10 μg/ml) for 5 days. Mean fluorescence intensities (MFIs) of MitoTracker Green (MTG) (K), MitoTracker deep red (MTDR) (L) [HC ( n = 31), irAE ( n = 18), RAC ( n = 32), and ICI ( n = 16)] or Cy5-linked-1-amino-glucose (GluCy5) (M) [HC ( n = 35), irAE ( n = 20), RAC ( n = 36), and ICI ( n = 18)] in CD8 + T cells were presented. Expression was normalized to the HC in each experiment. ( N ) UMAP shows the presence or absence of T cell receptor (TCR) in the major immune cells across all the samples. ( O ) Pie charts showing the distribution of the top 100 TCR clones across different T cell subsets. Data in graphs represent mean ± SEM. Significance was tested by one-way analysis of variance (ANOVA). [(A) to (E) and (G) to (O)] ICI, ICI control.
    Plate Bound Anti Cd3, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/invivomab+anti+mouse+cd3%CE%B5/InVivoMAb+anti-mouse+CD3%CE%B5/pm41865369-356-27-33
    Average 97 stars, based on 1 article reviews
    plate bound anti cd3 - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    97
    Bio X Cell anti cd28 bioxcell be0015
    ( A ) Circos plots showing the percentage of cells from HC (Healthy control, n = 6), ICI ( n = 2), RAC (RA control, n = 5), or irAE ( n = 5). ( B ) Expression of CD45RA and CCR7 on CD8 + T cells. Right: Summaries of the percentage of cells from HC ( n = 53), irAE ( n = 29), RAC ( n = 41), and ICI ( n = 26). ( C ) Expression of CXCR3 and CCR6 on CD8 + T cells. Right: Summaries of T cell subsets. HC ( n = 45), irAE ( n = 27), RAC ( n = 31), and ICI ( n = 26). ( D ) The cytotoxic score was evaluated using the gene list identified previously . ( E ) Specific genes were evaluated on CD8 + T cells. ( F ) Pathways that were significantly enriched in the CD8 + T cells between irAE and ICI. NF-κB, nuclear factor κB; STAT5, signal transducer and activator of transcription 5; DN, down. Gene set enrichment analysis (GSEA) plots of the allograft rejection ( G ), oxidative phosphorylation ( H ), IFN-α response ( I ), and IFN-γ response ( J ) between irAE and ICI. NES, normalized enrichment score ( K to M ) PBMCs were stimulated with <t>plate-coated</t> <t>anti-CD3</t> and anti-CD28 (10 μg/ml) for 5 days. Mean fluorescence intensities (MFIs) of MitoTracker Green (MTG) (K), MitoTracker deep red (MTDR) (L) [HC ( n = 31), irAE ( n = 18), RAC ( n = 32), and ICI ( n = 16)] or Cy5-linked-1-amino-glucose (GluCy5) (M) [HC ( n = 35), irAE ( n = 20), RAC ( n = 36), and ICI ( n = 18)] in CD8 + T cells were presented. Expression was normalized to the HC in each experiment. ( N ) UMAP shows the presence or absence of T cell receptor (TCR) in the major immune cells across all the samples. ( O ) Pie charts showing the distribution of the top 100 TCR clones across different T cell subsets. Data in graphs represent mean ± SEM. Significance was tested by one-way analysis of variance (ANOVA). [(A) to (E) and (G) to (O)] ICI, ICI control.
    Anti Cd28 Bioxcell Be0015, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/invivomab+anti+mouse+cd3%CE%B5/InVivoMAb+anti-mouse+CD3%CE%B5/pm41850247-246-154-155
    Average 97 stars, based on 1 article reviews
    anti cd28 bioxcell be0015 - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    97
    Bio X Cell invivomab anti bioxcell be0001 2 cd3 human cd3
    ( A ) Circos plots showing the percentage of cells from HC (Healthy control, n = 6), ICI ( n = 2), RAC (RA control, n = 5), or irAE ( n = 5). ( B ) Expression of CD45RA and CCR7 on CD8 + T cells. Right: Summaries of the percentage of cells from HC ( n = 53), irAE ( n = 29), RAC ( n = 41), and ICI ( n = 26). ( C ) Expression of CXCR3 and CCR6 on CD8 + T cells. Right: Summaries of T cell subsets. HC ( n = 45), irAE ( n = 27), RAC ( n = 31), and ICI ( n = 26). ( D ) The cytotoxic score was evaluated using the gene list identified previously . ( E ) Specific genes were evaluated on CD8 + T cells. ( F ) Pathways that were significantly enriched in the CD8 + T cells between irAE and ICI. NF-κB, nuclear factor κB; STAT5, signal transducer and activator of transcription 5; DN, down. Gene set enrichment analysis (GSEA) plots of the allograft rejection ( G ), oxidative phosphorylation ( H ), IFN-α response ( I ), and IFN-γ response ( J ) between irAE and ICI. NES, normalized enrichment score ( K to M ) PBMCs were stimulated with <t>plate-coated</t> <t>anti-CD3</t> and anti-CD28 (10 μg/ml) for 5 days. Mean fluorescence intensities (MFIs) of MitoTracker Green (MTG) (K), MitoTracker deep red (MTDR) (L) [HC ( n = 31), irAE ( n = 18), RAC ( n = 32), and ICI ( n = 16)] or Cy5-linked-1-amino-glucose (GluCy5) (M) [HC ( n = 35), irAE ( n = 20), RAC ( n = 36), and ICI ( n = 18)] in CD8 + T cells were presented. Expression was normalized to the HC in each experiment. ( N ) UMAP shows the presence or absence of T cell receptor (TCR) in the major immune cells across all the samples. ( O ) Pie charts showing the distribution of the top 100 TCR clones across different T cell subsets. Data in graphs represent mean ± SEM. Significance was tested by one-way analysis of variance (ANOVA). [(A) to (E) and (G) to (O)] ICI, ICI control.
    Invivomab Anti Bioxcell Be0001 2 Cd3 Human Cd3, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/invivomab+anti+mouse+cd3%CE%B5/InVivoMAb+anti-mouse+CD3%CE%B5/us12576160-251-52-54
    Average 97 stars, based on 1 article reviews
    invivomab anti bioxcell be0001 2 cd3 human cd3 - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    97
    Bio X Cell anti cd3 antibodies
    ( A ) Circos plots showing the percentage of cells from HC (Healthy control, n = 6), ICI ( n = 2), RAC (RA control, n = 5), or irAE ( n = 5). ( B ) Expression of CD45RA and CCR7 on CD8 + T cells. Right: Summaries of the percentage of cells from HC ( n = 53), irAE ( n = 29), RAC ( n = 41), and ICI ( n = 26). ( C ) Expression of CXCR3 and CCR6 on CD8 + T cells. Right: Summaries of T cell subsets. HC ( n = 45), irAE ( n = 27), RAC ( n = 31), and ICI ( n = 26). ( D ) The cytotoxic score was evaluated using the gene list identified previously . ( E ) Specific genes were evaluated on CD8 + T cells. ( F ) Pathways that were significantly enriched in the CD8 + T cells between irAE and ICI. NF-κB, nuclear factor κB; STAT5, signal transducer and activator of transcription 5; DN, down. Gene set enrichment analysis (GSEA) plots of the allograft rejection ( G ), oxidative phosphorylation ( H ), IFN-α response ( I ), and IFN-γ response ( J ) between irAE and ICI. NES, normalized enrichment score ( K to M ) PBMCs were stimulated with <t>plate-coated</t> <t>anti-CD3</t> and anti-CD28 (10 μg/ml) for 5 days. Mean fluorescence intensities (MFIs) of MitoTracker Green (MTG) (K), MitoTracker deep red (MTDR) (L) [HC ( n = 31), irAE ( n = 18), RAC ( n = 32), and ICI ( n = 16)] or Cy5-linked-1-amino-glucose (GluCy5) (M) [HC ( n = 35), irAE ( n = 20), RAC ( n = 36), and ICI ( n = 18)] in CD8 + T cells were presented. Expression was normalized to the HC in each experiment. ( N ) UMAP shows the presence or absence of T cell receptor (TCR) in the major immune cells across all the samples. ( O ) Pie charts showing the distribution of the top 100 TCR clones across different T cell subsets. Data in graphs represent mean ± SEM. Significance was tested by one-way analysis of variance (ANOVA). [(A) to (E) and (G) to (O)] ICI, ICI control.
    Anti Cd3 Antibodies, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/invivomab+anti+mouse+cd3%CE%B5/InVivoMAb+anti-mouse+CD3%CE%B5/pm41844609-369-57-59
    Average 97 stars, based on 1 article reviews
    anti cd3 antibodies - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Circos plots showing the percentage of cells from HC (Healthy control, n = 6), ICI ( n = 2), RAC (RA control, n = 5), or irAE ( n = 5). ( B ) Expression of CD45RA and CCR7 on CD8 + T cells. Right: Summaries of the percentage of cells from HC ( n = 53), irAE ( n = 29), RAC ( n = 41), and ICI ( n = 26). ( C ) Expression of CXCR3 and CCR6 on CD8 + T cells. Right: Summaries of T cell subsets. HC ( n = 45), irAE ( n = 27), RAC ( n = 31), and ICI ( n = 26). ( D ) The cytotoxic score was evaluated using the gene list identified previously . ( E ) Specific genes were evaluated on CD8 + T cells. ( F ) Pathways that were significantly enriched in the CD8 + T cells between irAE and ICI. NF-κB, nuclear factor κB; STAT5, signal transducer and activator of transcription 5; DN, down. Gene set enrichment analysis (GSEA) plots of the allograft rejection ( G ), oxidative phosphorylation ( H ), IFN-α response ( I ), and IFN-γ response ( J ) between irAE and ICI. NES, normalized enrichment score ( K to M ) PBMCs were stimulated with plate-coated anti-CD3 and anti-CD28 (10 μg/ml) for 5 days. Mean fluorescence intensities (MFIs) of MitoTracker Green (MTG) (K), MitoTracker deep red (MTDR) (L) [HC ( n = 31), irAE ( n = 18), RAC ( n = 32), and ICI ( n = 16)] or Cy5-linked-1-amino-glucose (GluCy5) (M) [HC ( n = 35), irAE ( n = 20), RAC ( n = 36), and ICI ( n = 18)] in CD8 + T cells were presented. Expression was normalized to the HC in each experiment. ( N ) UMAP shows the presence or absence of T cell receptor (TCR) in the major immune cells across all the samples. ( O ) Pie charts showing the distribution of the top 100 TCR clones across different T cell subsets. Data in graphs represent mean ± SEM. Significance was tested by one-way analysis of variance (ANOVA). [(A) to (E) and (G) to (O)] ICI, ICI control.

    Journal: Science Advances

    Article Title: Inflammatory arthritis irAE may represent a unique autoimmune disease primarily driven by T cells but likely not autoantibodies

    doi: 10.1126/sciadv.aea4262

    Figure Lengend Snippet: ( A ) Circos plots showing the percentage of cells from HC (Healthy control, n = 6), ICI ( n = 2), RAC (RA control, n = 5), or irAE ( n = 5). ( B ) Expression of CD45RA and CCR7 on CD8 + T cells. Right: Summaries of the percentage of cells from HC ( n = 53), irAE ( n = 29), RAC ( n = 41), and ICI ( n = 26). ( C ) Expression of CXCR3 and CCR6 on CD8 + T cells. Right: Summaries of T cell subsets. HC ( n = 45), irAE ( n = 27), RAC ( n = 31), and ICI ( n = 26). ( D ) The cytotoxic score was evaluated using the gene list identified previously . ( E ) Specific genes were evaluated on CD8 + T cells. ( F ) Pathways that were significantly enriched in the CD8 + T cells between irAE and ICI. NF-κB, nuclear factor κB; STAT5, signal transducer and activator of transcription 5; DN, down. Gene set enrichment analysis (GSEA) plots of the allograft rejection ( G ), oxidative phosphorylation ( H ), IFN-α response ( I ), and IFN-γ response ( J ) between irAE and ICI. NES, normalized enrichment score ( K to M ) PBMCs were stimulated with plate-coated anti-CD3 and anti-CD28 (10 μg/ml) for 5 days. Mean fluorescence intensities (MFIs) of MitoTracker Green (MTG) (K), MitoTracker deep red (MTDR) (L) [HC ( n = 31), irAE ( n = 18), RAC ( n = 32), and ICI ( n = 16)] or Cy5-linked-1-amino-glucose (GluCy5) (M) [HC ( n = 35), irAE ( n = 20), RAC ( n = 36), and ICI ( n = 18)] in CD8 + T cells were presented. Expression was normalized to the HC in each experiment. ( N ) UMAP shows the presence or absence of T cell receptor (TCR) in the major immune cells across all the samples. ( O ) Pie charts showing the distribution of the top 100 TCR clones across different T cell subsets. Data in graphs represent mean ± SEM. Significance was tested by one-way analysis of variance (ANOVA). [(A) to (E) and (G) to (O)] ICI, ICI control.

    Article Snippet: A total of 0.5 million isolated CD4 + T cells or CD8 + T cells was stimulated with plate-coated anti-CD3 (10 μg/ml; BioXCell, catalog no. BE0001-2) and anti-CD28 (BioXCell, catalog no. BE0291), rhIL-6 (100 ng/ml), rhIFN-α 2 (100 ng/ml), rhIL-12 (100 ng/ml), or the combination of rhIL-6, rhIFN-α 2 , and rhIL-12 for 5 days.

    Techniques: Control, Expressing, Phospho-proteomics, Fluorescence, Clone Assay

    ( A ) The CD4/CD8 ratio in PBMCs. HC ( n = 53), irAE ( n = 23), RAC ( n = 42), and ICI ( n = 17). ( B ) Expression of CD25 and CD127 on CD4 + T cells. HC ( n = 53), irAE ( n = 27), RAC ( n = 42), and ICI ( n = 17). ( C ) Expression of CXCR5 and CD4 on the CD45RA − CD4 + T cells. HC ( n = 53), irAE ( n = 27), RAC ( n = 42), and ICI ( n = 17). ( D ) Expression of CCR6 and CXCR3 on CD45RA − CD4 + T cells. HC ( n = 41), irAE ( n = 26), RAC ( n = 36), and ICI ( n = 12). ( E ) Significantly enriched pathways in CD4 + T cells between irAE and ICI. UV, ultraviolet. GSEA plots of IFN-α and IFN-γ response ( F ), and oxidative phosphorylation ( G ). ( H to M ) PBMCs were stimulated with plate-coated anti-CD3/CD28 (10 μg/ml) for 5 days; MFI of MTDR (H; HC, n = 31; irAE, n = 18; RAC, n = 32; ICI, n = 16), tetramethylrhodamine methyl ester (TMRM) (I; HC, n = 34; irAE, n = 19; RAC, n = 35; ICI, n = 17), or GluCy5 (J; HC, n = 35; irAE, n = 20; RAC, n = 36; ICI, n = 18) in CD4 + T cells were presented. Expression was normalized to the HC in each experiment. [(K) to (M)] Fresh PBMCs were stimulated with phorbol 12-myristate 13-acetate (PMA), ionomycin, and monensin for 5 hours, and the frequencies of perforin + [(K); HC, n = 27; irAE, n = 13; RAC, n = 12; ICI, n = 8], [TNF-α + (L), and IL-2 + (M) (HC, n = 44; irAE, n = 25; RAC, n = 27; ICI, n = 16] CD4 + T cells were examined. Data in graphs represent mean ± SEM. Significance was tested by one-way ANOVA. [(A) to (D) and (F) to (M)] ICI, ICI control.

    Journal: Science Advances

    Article Title: Inflammatory arthritis irAE may represent a unique autoimmune disease primarily driven by T cells but likely not autoantibodies

    doi: 10.1126/sciadv.aea4262

    Figure Lengend Snippet: ( A ) The CD4/CD8 ratio in PBMCs. HC ( n = 53), irAE ( n = 23), RAC ( n = 42), and ICI ( n = 17). ( B ) Expression of CD25 and CD127 on CD4 + T cells. HC ( n = 53), irAE ( n = 27), RAC ( n = 42), and ICI ( n = 17). ( C ) Expression of CXCR5 and CD4 on the CD45RA − CD4 + T cells. HC ( n = 53), irAE ( n = 27), RAC ( n = 42), and ICI ( n = 17). ( D ) Expression of CCR6 and CXCR3 on CD45RA − CD4 + T cells. HC ( n = 41), irAE ( n = 26), RAC ( n = 36), and ICI ( n = 12). ( E ) Significantly enriched pathways in CD4 + T cells between irAE and ICI. UV, ultraviolet. GSEA plots of IFN-α and IFN-γ response ( F ), and oxidative phosphorylation ( G ). ( H to M ) PBMCs were stimulated with plate-coated anti-CD3/CD28 (10 μg/ml) for 5 days; MFI of MTDR (H; HC, n = 31; irAE, n = 18; RAC, n = 32; ICI, n = 16), tetramethylrhodamine methyl ester (TMRM) (I; HC, n = 34; irAE, n = 19; RAC, n = 35; ICI, n = 17), or GluCy5 (J; HC, n = 35; irAE, n = 20; RAC, n = 36; ICI, n = 18) in CD4 + T cells were presented. Expression was normalized to the HC in each experiment. [(K) to (M)] Fresh PBMCs were stimulated with phorbol 12-myristate 13-acetate (PMA), ionomycin, and monensin for 5 hours, and the frequencies of perforin + [(K); HC, n = 27; irAE, n = 13; RAC, n = 12; ICI, n = 8], [TNF-α + (L), and IL-2 + (M) (HC, n = 44; irAE, n = 25; RAC, n = 27; ICI, n = 16] CD4 + T cells were examined. Data in graphs represent mean ± SEM. Significance was tested by one-way ANOVA. [(A) to (D) and (F) to (M)] ICI, ICI control.

    Article Snippet: A total of 0.5 million isolated CD4 + T cells or CD8 + T cells was stimulated with plate-coated anti-CD3 (10 μg/ml; BioXCell, catalog no. BE0001-2) and anti-CD28 (BioXCell, catalog no. BE0291), rhIL-6 (100 ng/ml), rhIFN-α 2 (100 ng/ml), rhIL-12 (100 ng/ml), or the combination of rhIL-6, rhIFN-α 2 , and rhIL-12 for 5 days.

    Techniques: Expressing, Phospho-proteomics, Control

    ( A to G ) PBMCs from the patients with irAE were cultured in the plate coated with anti-CD3 and anti-CD28 (10 μg/ml) in the presence of IgG1 isotype control or anti–human IL-6R (50 μg/ml), anti–human IL-12p40 (50 μg/ml), and anti–human IFNAR1 (50 μg/ml) for 3 days; n = 9. (A) Expression of CD38 and CD127 on CD8 + T cells. Right: Percentage of CD38 + CD127 − CD8 + T cells. (B and C) CD8 + T cells activated for 5 days were restimulated with PMA, ionomycin, and monensin for 5 hours. (B) Expression of granzyme B and IFN-γ. Right: Percentage of granzyme B + IFN-γ + CD8 + T cells. (C) Expression of perforin and IFN-γ. Right: Percentage of perforin + IFN-γ + CD8 + T cells. [(D) and (E)] MFIs of GluCy5 (D), TMRM, and MTDR (E) in CD8 + T cells were presented. [(F) and (G)] CD4 + T cells activated for 5 days were restimulated with PMA, ionomycin, and monensin for 5 hours. (F) Expression of IL-21 and IL-2. Right: Percentage of IL-21 + IL-2 + CD4 + T cells. (G) Expression of CD38 and CXCR5 on CD4 + T cells. Right: Percentage of CD38 + CXCR5 − CD4 + T cells. Data in graphs represent mean ± SEM. Significance was tested paired Student’s t test [(A) to (G)].

    Journal: Science Advances

    Article Title: Inflammatory arthritis irAE may represent a unique autoimmune disease primarily driven by T cells but likely not autoantibodies

    doi: 10.1126/sciadv.aea4262

    Figure Lengend Snippet: ( A to G ) PBMCs from the patients with irAE were cultured in the plate coated with anti-CD3 and anti-CD28 (10 μg/ml) in the presence of IgG1 isotype control or anti–human IL-6R (50 μg/ml), anti–human IL-12p40 (50 μg/ml), and anti–human IFNAR1 (50 μg/ml) for 3 days; n = 9. (A) Expression of CD38 and CD127 on CD8 + T cells. Right: Percentage of CD38 + CD127 − CD8 + T cells. (B and C) CD8 + T cells activated for 5 days were restimulated with PMA, ionomycin, and monensin for 5 hours. (B) Expression of granzyme B and IFN-γ. Right: Percentage of granzyme B + IFN-γ + CD8 + T cells. (C) Expression of perforin and IFN-γ. Right: Percentage of perforin + IFN-γ + CD8 + T cells. [(D) and (E)] MFIs of GluCy5 (D), TMRM, and MTDR (E) in CD8 + T cells were presented. [(F) and (G)] CD4 + T cells activated for 5 days were restimulated with PMA, ionomycin, and monensin for 5 hours. (F) Expression of IL-21 and IL-2. Right: Percentage of IL-21 + IL-2 + CD4 + T cells. (G) Expression of CD38 and CXCR5 on CD4 + T cells. Right: Percentage of CD38 + CXCR5 − CD4 + T cells. Data in graphs represent mean ± SEM. Significance was tested paired Student’s t test [(A) to (G)].

    Article Snippet: A total of 0.5 million isolated CD4 + T cells or CD8 + T cells was stimulated with plate-coated anti-CD3 (10 μg/ml; BioXCell, catalog no. BE0001-2) and anti-CD28 (BioXCell, catalog no. BE0291), rhIL-6 (100 ng/ml), rhIFN-α 2 (100 ng/ml), rhIL-12 (100 ng/ml), or the combination of rhIL-6, rhIFN-α 2 , and rhIL-12 for 5 days.

    Techniques: Cell Culture, Control, Expressing